The Pediatric Multidisciplinary Musculoskeletal Oncology Conference is an interactive, interdisciplinary forum that serves to review all cases of musculoskeletal and related tumors and to strategize appropriate interdisciplinary plans of care.
Multidisciplinary care has been shown to improve outcomes. This is a working meeting to review patient issues and make decisions about ongoing care.
The Multidisciplinary Solid Tumor Board reviews multiple complex patient cases each week. This conference promotes collaboration among clinical providers to optimize selection of therapies for patients, based on mutual review of radiographic and pathologic material. Surgical, medical, radiology, and pathology providers have different educational backgrounds and biases which are reduced or eliminated by group review and consensus-building.
It is documented that care is superior when provided in a multi-disciplinary format. Appropriate treatment of solid tumors therefore involves a multidisciplinary approach to diagnosis, review of response, and both initial and ongoing care planning. Development of care plans in this context promotes both improved outcomes and improved patient satisfaction.
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 1.5 hours of participation for continuing education for allied health professionals.
- Describe and discuss contemporary issues in the diagnosis, treatment, and evaluation of pediatric patients with musculoskeletal tumors.
- Formulate data-driven, interdisciplinary plans of care for patients presenting with musculoskeletal tumors.
- Identify gaps in the literature related to the care of pediatric patients with musculoskeletal tumors.
- 1.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.50 Hours of ParticipationHours of Participation credit.